NCT03092505View on ClinicalTrials.gov

Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

February 1, 2021

Study Completion Date

February 4, 2021

Conditions
Herpes Virus-Related Illnesses
Trial Locations (2)

20892

National Institutes of Health Clinical Center, Bethesda

Unknown

Rakai, Kalisizo, and Villa Maria Hospital, Kalisizo

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03092505 - Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA) | Biotech Hunter | Biotech Hunter